PDEX - הכנסה תפעולית לפני ניכוי פחת Pro-Dex

Changes in EBITDA_Co demonstrate the financial resilience of Pro-Dex, Inc. (PDEX), where 14.80 describes the current status of the metric. The issuer possesses strong pricing power due to the creation of unique micro-actuators. Management is betting on precision accuracy and close ties with partners. Business stability relies on long-term agreements with medical leaders while maintaining healthy margins.

This indicator captures the actual cash flow from core operations before debt and tax obligations, reflecting the fundamental stability of the business. The current absolute EBITDA volume of 14.80 confirms the ability of Pro-Dex, Inc. (PDEX) to convert its technological superiority in the production of high-precision surgical micromotors into stable operating income, which is critical for assessing capitalization within the high-tech medical sector.